Screener
Bristol-Myers Squibb BMY Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's enterprise value?
- Bristol-Myers Squibb (BMY) reported enterprise value of $152.27B in Q2 2026.
- How has Bristol-Myers Squibb's enterprise value changed year-over-year?
- Bristol-Myers Squibb's enterprise value increased by 14.9% year-over-year, from $132.49B to $152.27B.
- What is the long-term trend for Bristol-Myers Squibb's enterprise value?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's enterprise value has grown at a -3.4% compound annual growth rate (CAGR), from $174.56B to $146.74B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Bristol-Myers Squibb's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude